Comparing muscarinic receptor subtype expression levels in adenocarcinoma vs. normal colon samples, we consistently observed reduced CHRM1, CHRM2, and CHRM4 and increased CHRM3 RNA levels (log2fc normal relative to cancer tissue; Figure 6). This evidence concerns the gene CHRM1 and adenocarcinoma.